News
News Center
Focus on breathing, medical symbiosis┊ Jiuhua Huayuan Pharmaceutical Co., Ltd. congratulates on the grand convening of the 4th China Symposium on Respiratory Diseases Integrating Chinese and Western Medicine
Release time:
2020-09-10 09:43
Source:
From September 4th to September 5th, sponsored by China Traditional Chinese Medicine Association, jointly organized by China Traditional Chinese Medicine Association Respiratory Drug Research Professional Committee, Anhui University of Traditional Chinese Medicine and China Traditional Chinese Medicine Association Drug Research Evaluation Technology Center The academic seminar and the 2020 Annual Meeting of the Respiratory Drug Research Professional Committee of the China Association of Traditional Chinese Medicine were held in Hefei Fengda International Hotel.
Conference opening ceremony
Focus on breathing, integration of Chinese and Western, medical symbiosis
This conference has 1 main venue and 3 sub-forums, and about 1,000 experts and scholars participated in the conference. The meeting solemnly invited members of the WHO joint inspection expert group, experts from the Central New Coronary Pneumonia Epidemic Prevention and Control Steering Group, and front-line Chinese and Western medicine clinical experts to give special reports, focusing on a series of key issues in epidemic prevention and control, and at the same time on respiratory influenza. Similar diseases, asthma, chronic obstructive pulmonary disease, and respiratory critical illnesses. On the eve of the opening ceremony of the conference, the Youth Respiratory Forum was held to build an academic exchange platform for young physicians to showcase the all-round talents of young respiratory physicians. At the same time, a standardized project research and lecture tour of the "Guidelines for Clinical Application of Chinese Patent Medicines for the Treatment of Advantageous Diseases", which was established by the Administration of Traditional Chinese Medicine, was held. Training, sorting out domestic and foreign research results on the prevention and treatment of new coronary pneumonia, summarizing clinical experience, integrating Chinese and Western medicine clinical experts, sorting out industry standards, and improving the level of clinical diagnosis and treatment of respiratory diseases in my country.
Anti-epidemic heroes, ordinary and great
The Spring Festival in early 2020 is so different from the past, the new crown pneumonia virus is quietly raging, and the epidemic will isolate us. However, in this era, there are always heroes who are recklessly "retrograde". The fight against the epidemic is a battlefield without the smoke of gunpowder, but there are tests of life and death. We have seen stalwart figures, remembered ordinary names, and were moved by warm stories. It is precisely because of these heroes who walk against the wind, the "angels in white" who protect life with their lives, they are well-deserved heroes. , is the cutest person of this era.
The special academic meeting of Bairui granules, discussing the development of respiratory disease
On September 5, an academic symposium on "Research on Proprietary Chinese Medicines in the Field of Respiratory Infection Prevention and Control" sponsored by Anhui Jiuhua Huayuan Pharmaceutical Co., Ltd. was held on time at Venue 1 (Infection Forum). The meeting invited Professor Lin Jiangtao, Professor of Respiratory and Critical Care Medicine and Doctoral Supervisor of China-Japan Friendship Hospital, Chairman of the Professional Committee of Respiratory Medicine Research of China Association of Traditional Chinese Medicine, as the chairman of the conference, Vice President of Anhui University of Traditional Chinese Medicine, Research on Respiratory Medicine of China Association of Traditional Chinese Medicine The vice chairman of the professional committee, Prof. Li Zegeng served as the speaker of the conference. Professor Li gave a wonderful speech on the epidemiology of respiratory tract infection, understanding of traditional Chinese medicine, and the advantages of Chinese patent medicine in the treatment of respiratory tract infections. Taking Bairui granules produced in Chuzhou, Anhui as an example, he introduced Bairui as the origin of Hui medicine culture and as a The single-party anti-infective botanical medicine has the exact curative effect on the clinical treatment of respiratory infectious diseases. Professor Lin Jiangtao made a wonderful comment on this academic symposium and recommended the promotion and use of Bairui Granules in clinical practice.
In addition, our company launched a WeChat lottery and answering activity at the booth, which attracted many participating experts and scholars to visit and give guidance, and cordially communicated with our staff to express their recognition and appreciation for Bairui Granules.
The conference officially ended on September 5. Our company would like to extend our most sincere congratulations to the successful conclusion of the conference. As a unilateral anti-infective botanical drug, Bairui Granules is safe, suitable for a wide range of people and treats both symptoms and symptoms. It has always been widely favored by doctors and patients in the respiratory field. Our company will continue to work with the Respiratory Branch of the China Association of Traditional Chinese Medicine, maintain the entrepreneurial spirit of positive progress, win-win cooperation, and medical symbiosis, and strive to benefit more patients in the respiratory field!
The conference officially ended on September 5. Our company would like to extend our most sincere congratulations to the successful conclusion of the conference. As a unilateral anti-infective botanical drug, Bairui Granules is safe, suitable for a wide range of people and treats both symptoms and symptoms. It has always been widely favored by doctors and patients in the respiratory field. Our company will continue to work with the Respiratory Branch of the China Association of Traditional Chinese Medicine, maintain the entrepreneurial spirit of positive progress, win-win cooperation, and medical symbiosis, and strive to benefit more patients in the respiratory field!
Related News
2024-09-30
2024-09-30
